2023 PRMRP Awarded Projects

In 2020, Congress for the first time included “peripheral neuropathy” as an eligible condition for study through a $370 million fund administered by the Department of Defense (DoD) known as the “Peer Reviewed Medical Research Program (PRMRP).” This important breakthrough was a direct result of the nationwide advocacy of the peripheral neuropathy community. This accomplishment has allowed our research community to apply for funding from a federal program to which they previously did not have access. The PRMRP is specifically focused on high-risk, high-reward research that will lead to new, tangible outcomes such as new therapeutics and treatments. Every year, Congress determines the conditions that are eligible for study through the PRMRP by listing them in the Senate version of the annual Defense Appropriations Act. Below are the peripheral neuropathy-related projects that will receive funding as part of the 2023 bill.

2023 PRMRP Awarded Projects:

A Novel miR-155 Therapy for the Treatment of Peripheral Neuropathy

Principal Investigator: JARIWALA, SHAILLY
Institution Receiving Award: HENRY M. JACKSON FOUNDATION
Program: PRMRP
Proposal Number: PR230358
Funding Mechanism: Discovery Award
Award Amount: $319,151.00

Read Project Abstract

Targeting Local B Cells to Prevent Chronification of Neuropathic Pain

Principal Investigator: GRACE, PETER
Institution Receiving Award: MD ANDERSON CANCER CENTER, UNIVERSITY OF TEXAS
Program: PRMRP
Proposal Number: PR231201
Funding Mechanism: Investigator-Initiated Research Award – Partnering PI Option
Award Amount: $3,064,079.00

Read Project Abstract

Targeting Local B Cells to Prevent Chronification of Neuropathic Pain

Principal Investigator: HEIJNEN, COBI
Institution Receiving Award: RICE UNIVERSITY
Program: PRMRP
Proposal Number: PR231201P1
Funding Mechanism: Investigator-Initiated Research Award – Partnering PI Option
Award Amount: $165,704.00

Read Project Abstract